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Polycrystalline phenomena with solvates are not uncommon for
many known drugs. The incorporation of solvent molecules results
in the formation of new crystalline forms. This has attracted the
attention of drug researchers. It is well known that the polymorphs
of a substance are chemically identical but can differ signiﬁcantly
in their pharmaceutically relevant properties, such as solubility1,2,
dissolution rate3, and density, which can affect their bioavail-
ability, membrane permeability4 and efﬁcacy in drug formula-
tions5. The term “polymorphism” describes a phenomenon in
which crystal structures of a substance are deﬁned by different unit
cells, and yet each of the forms has the same elemental composi-
tion. Along this same line, “solvatomorphism” encompasses
crystals of a substance deﬁned by different unit cells, but these
unit cells differ in their elemental composition through the
inclusion of solvent molecules6. For greater insight into the
regularities of solvents in crystal lattices, single-crystal X-ray
diffraction (SCXRD) is suitable for detecting solvent structure and
molecular interactions with the drug substance, and is particularly
useful in the research of polymorphs7. In drug development, the
formation of solvates has some relationship with the drug's
preparation and production8, and guest solvent molecules con-
tribute signiﬁcantly to the stabilization of crystalline samples and
their molecular conformation9. For instance, solvated forms of
paclitaxel, an anticancer drug, were found to be useful intermedi-
ates10. Solvates can also be used as the medicinal forms in clinical
treatment. For example, cabazitaxel, another anticancer drug, is a
1:1 acetone solvate (form A) as a commercially available raw
material11.
This paper focuses on the well-known drug bifendate (dimethyl-
4,40-dimethoxy-5,6,50,60-dimethylenedioxybiphenyl-2,20-dicarbox-
ylate, Fig. 1A), a synthetic hepatoprotective agent derived from
schisandrin C12,13. Bifendate displays a remarkable hepatoprotec-
tive ability against chemical liver injury induced by tetrachloride
or ethanol as well as other solvents14 by lowering alanine
transaminase (ALT) activity and protecting the liver in
patients15,16, and is widely used for the management of chronic
hepatitis in China17–19. Bifendate exhibits the phenomenon of
polymorphism. However, to date, only two polymorphs of
bifendate with melting point values of 178–180 1C (form A) and
159–161 1C (form B), respectively, are currently established in the
literature20. No studies on the crystal structures of bifendate have
yet been reported. Consequently, in order to understand both the
molecular conformational states in crystal lattices and their
packing architectures, to investigate the reasons for polymorphism
or solvatomorphism at the atomic scale, and to obtain the standardFigure 1 Chemical structure and structural overlay for forms B–E of bifen
red, solvate D is in blue, solvate E is in green. (A) Chemical structure of
solvates C–E.PXRD patterns for different forms of bifendate, herein a study of
the preparation and structural characterization of the bifendate
polymorphs and solvatomorphs using SCXRD, thermal analysis
and Fourier transform infrared spectrometry (FT-IR) was carried
out. Following numerous crystallization attempts the known
polymorph, form B, was produced, plus three new solvates,
referred to as forms C, D, and E denoting bifendate with
tetrahydrofuran, dioxane, and pyridine, respectively, in 1:1 molar
ratios. SCXRD conﬁrmed that the molecular conformations were
different among distinct forms of bifendate and the simulated
PXRD patterns of four forms were calculated followed by the
crystallographic data of forms B–E. This provided some scientiﬁc
basis for the formation of bifendate polymorphs.2. Materials and methods
2.1. Materials
Bifendate (white powder, C20H18O10, MW 418.36, Z99.6%) was
purchased from Hubei Jianyuan Chemical Engineering Inc. (Batch
No. 20100707, Hubei, China) and used without further puriﬁca-
tion. All reagents used for this study were of analytical grade and
purchased from Sinopharm Chemical Reagent Company Ltd.
(Shanghai, China). Demineralized distilled water was used to
prepare buffers.
2.2. Preparation of samples
Bifendate crystalline form B and crystallosolvates with tetrahy-
drofuran (C), dioxane (D) and pyridine (E) were obtained from the
ﬁltered acetonitrile–water mixture (3.5:1, v/v), tetrahydrofuran,
dioxane–water mixture (3:1, v/v) and pyridine solutions, respec-
tively, by slow evaporation at ambient conditions after 10, 4, 6 and
20 days, respectively.
2.3. General techniques
2.3.1. Single-crystal X-ray diffraction (SCXRD)
The X-ray diffraction experiments were carried out on a Rigaku
MicroMax-002þ CCD diffractometer with CuKα radiation
(λ¼1.54178 Å) at 293 K (Rigaku, Americas, the Woodlands,
Texas, USA). Absorption correction and integration of the
collected data were handled using the CrystalClear software
package (Rigaku Americas). The crystal structures were solved
by the direct method followed by Fourier syntheses with
SHELXS–97 and then reﬁned by full-matrix least-squaresdate. Eight molecules of form B are in different colors, solvate C is in
bifendate; (B) overlay of eight molecules of form B; (C) overlay of
Jinju Nie et al.236procedures using SHELXL–97 on F2 with anisotropic displace-
ment parameters (ADPs) for non-hydrogen atoms. The H atoms
were placed in calculated positions and included in the ﬁnal cycles
of reﬁnement in the riding modes21. To help data convergence,
some restraints were introduced to the reﬁnement of disorders22.
The PLATON program with the probe radius of 1.2 Å was also
employed to calculate the volume of the channels where the
solvents resided in an asymmetric unit of solvates23.
2.3.2. Calculation of powder X-ray diffractometric patterns
The MERCURY software (version 3.3, Cambridge crystallo-
graphic data center, Cambridge, UK)24, with the conditions of
start angle, 31 stop angle, 401 step size, 0.021, was adopted to
calculate the simulated powder X-ray pattern for a CuKα radiation.
2.3.3. Thermal analysis
To investigate the stoichiometry between the guests and the hosts
for solvates, thermal gravimetric analysis (TGA) was performed on
a Mettler Toledo DSC/TGA 1 calorimeter (Mettler Toledo,
Greifensee, Switzerland). Approximately 10 mg of the sample
was added to an aluminum oxide cell and heated over the
temperature range of 30–500 1C at a constant heating rate of
10 1C/min and purged with a stream of ﬂowing dry nitrogen
throughout the experiment at 50 mL/min.
To better understand the thermal events, differential scanning
calorimetry (DSC) was also introduced to monitor the desolvation
process and determine the melting temperature of correspondingTable 1 Crystallographic data and experimental details for four crys
Parameter Form B Form
Empirical formula C20H18O10 C20H1
Molecular weight (Da) 418.36 490.45
Crystal system Triclinic Orthor
Space group P 1 P na21
Color/shape Colorless/Prism Colorl
Crystal size (mm3) 0.45 0.60 0.79 0.19
Temperature (K) 293(2) 293(2)
a (Å) 16.305(3) 8.516(
b (Å) 16.312(3) 21.957
c (Å) 29.042(6) 12.429
α (1) 97.68(3) 90.00
β (1) 97.64(3) 90.00
γ (1) 90.03(3) 90.00
Volume (Å3) 7,586(3) 2,324.
Z 16 4
dcalcd (g/cm
3) 1.465 1.402
F (0 0 0) 3,488 1,032
Absorption coefﬁcient (mm1) 1.023 0.950
Theta range for data collection (1) 1.55–72.65 4.03–7
Reﬂections collected 107,349 12,118
Independent reﬂections 28,817 3,871
Rint 0.0933 0.0487
R1 [I42σ(I)] 0.0654 0.0530
wR2 [I42σ(I)] 0.1571 0.1445
R1 (all) 0.0904 0.0579
wR2 (all) 0.1765 0.1533
Goodness-of-ﬁt on F2 0.998 1.045
Completeness 0.956 0.990
CCDC deposition number 1,432,083 1,432,solvates using a Mettler Toledo DSC 1 calorimeter (Mettler
Toledo) with the STARe software package (Mettler Toledo) for
Microsoft Windows. The samples were weighed into perforated
aluminum sample pans (40 μL) and heated at the rate of 10 1C/min
from 30 to 200 1C.
2.3.4. FT-IR spectroscopy
FT-IR spectra were recorded with a PerkinElmer Spectrum 400
FT-IR spectrophotometer (PerkinElmer, Waltham, Massachusetts,
USA) using an attenuated total reﬂectance sampling accessory in
the scan range of 650–4000 cm1 with a resolution of 4 cm1,
and then processed via the SPECTRUM software suite
(PerkinElmer).3. Results
3.1. Crystal structure
As internationally recognized, SCXRD can provide precise
structural information for polymorphic compositions about mole-
cular conformations, spatial arrangements of molecules and the
way that molecules interact. To acquire the relevant information
for different forms of bifendate, SCXRD was used to characterize
forms B–E. Crystal data and reﬁnement conditions for form B to E
are summarized in Table 1. In all four forms, the molecular
conformations were comparable, comprising two essentially planar
units with the planes linked by the C–C bond of biphenyl group.talline forms of bifendate.
C Form D Form E
8O10 C4H8O C20H18O10 C4H8O2 C20H18O10 C5H5N
506.45 497.44
hombic Orthorhombic Orthorhombic
P 212121 P na21
ess/Prism Colorless/Prism Colorless/Prism
0.27 0.61 0.39 0.78 0.83 0.59 0.76 0.99
293(2) 293(2)
2) 8.473(3) 8.555(2)
(4) 12.529(3) 22.243(4)
(2) 22.728(5) 12.207(2)
90.00 90.00
90.00 90.00
90.00 90.00
0(8) 2,412.8(12) 2,322.8(8)
4 4
1.394 1.422
1,064 1,040
0.965 0.943
2.21 3.89–71.72 3.97–71.97
14,611 14,776
4,521 3,291
0.0623 0.0636
0.0454 0.0522
0.1149 0.1279
0.0482 0.0535
0.1190 0.1299
1.059 1.064
0.986 0.978
084 1,432,085 1,432,086
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dered together with intermolecular interactive mode, and the
simulated PXRD patterns of the four forms were calculated.
SCXRD analysis revealed that form B of bifendate belonged to
P 1 space group, triclinic crystal system while solvates C and E
crystallized in the orthorhombic space group P na21, P 212121, and
P na21, respectively. Form B was a non-solvated polymorph, with
the asymmetric unit composed of 8 molecules, and 16 molecules
located in the unit cell. The basic molecular skeleton for bifendate
was a biphenyl structure, consisting of 2 symmetrical fragments, in
which both of the 5- and 6-membered rings were almost planar
and coplanar. The guest solvent molecules of solvate C–E were
tetrahydrofuran, dioxane and pyridine, respectively, in stoichio-
metry 1:1 with the host molecule. For the three solvates, the basic
unit contained one bifendate molecule and one solvent molecule,
which had a higher temperature factor because of the disordered
thermal motion of the solvent molecule. The dihedral angles
between two planar fragments linked by the C–C bond of the
biphenyl group of forms B–E are shown in Table 2, which
displayed obvious differences among the four forms.
The crystal density value of form B was higher than those of
forms C to E, illustrating that the bifendate molecules were
arranged tightly in three-dimensional space, and the calculated
volume (103.7 Å3) of solvent-accessible voids per the unit-cell
volume in form B was 1.4%. Comparing that with form B, it was
easy to see that all the molecules in the structures of forms C to E
were arranged loosely with the corresponding calculated volume
of 537.2 Å3 (C), 644.6 Å3 (D), and 534.9 Å3 (E) accounting for
approximately 23.1%, 26.7%, and 23.0% of unit-cell volume.
3.1.1. Conformational analysis
Fig. 1B shows a structure overlay for form B of bifendate, with
two molecules in different conformational states in an asymmetry
unit, and in which the two symmetrical fragments linked by the C–
C bond from the biphenyl group were not coplanar, with the
corresponding torsion angles being 69.31 and 69.31, respec-
tively. Apart from that, and despite two methyl ester side chains in
each molecule directed to the identical side owing to the single-
bonding rotations, two different orientations were shown for theTable 2 Dihedral angles between the ring planes linked by
C–C bond of the biphenyl group.
Form ∠R1–R2 (1)a
B (A) 71.3
C 125.3
D 125.7
E 126.7
aR1 denotes the C1/C2/C3/C4/C5/O4/C16/O5/C6 ring; R2
denotes the C7/C12/C11/C10/C9/O7/C17/O6/C8 ring.
Table 3 Torsion angle values describing conformational states of bi
Form ∠C6–C1–C7–C8 ∠C15–O3–C4–C3 ∠C1–C
B (A/C) 69.3(3)/69.3(3) 6.4(3)/5.5(3) 21.8(4)
C 120.7(3) 9.5(6) 25.6
D 121.3(2) 11.8(4) 27.8(3)
E 122.1(3) 7.2(5) 30.2molecules, including the methoxyl fragments. To better describe
the molecular conformational state the relative torsion angles in the
basic unit for the 4 forms were calculated and are listed in Table 3.
Structure overlay for 3 solvates of bifendate are shown in Fig. 1C;
it is clear that the host molecules also displayed 2 different
molecular conformations for the solvates. Among these, the host
molecules in forms C and E adopted the same conformation of the
C–C bond of biphenyl group rotating outwards from the paper,
with the torsion angle of 120.7(3)1 and 122.1(3)1, respectively,
while that of solvate D rotated in an inward direction and the
torsion angle was 121.3(2)1. In addition, with regard to the
single bond rotations, signiﬁcant differences in the orientation of
methyl ester and methoxyl were observed among the three
solvates; several of the methoxyl fragments of form D were
turned to the identical side in comparison with those in forms C
and E, which were pointed to two different sides. Secondly,
although a pair of methyl ester groups for each solvate were
turned to the identical side, those in solvate D were discovered to
adopt to the opposite orientation with respect to those of solvates
C and E.
3.1.2. Intermolecular interaction
As depicted in Fig. 2, in the crystal structure of form B, non-
classical hydrogen bonds and weak π-π stacking interactions
played an important role in forming a supramolecular structure.
The host molecules were assembled into a one-dimensional chain
along the [0 0 1] direction via weak π-π stacking interactions
between the phenyl rings and the oxygenic heterocyclic rings.
Together with the non-classical hydrogen bonds, a two-
dimensional layer parallel to the (0 0 1) plane can be constructed.
When the non-classical hydrogen bonds and van der Waals forces
were considered together, a three-dimensional supramolecular
structure was completed in the crystal structure. Meanwhile,
layered structures of solvates C–E with solvent molecules located
in the channels between the layers for solvates C to E are shown in
Fig. 3A–C. It was disclosed that the guest solvent molecules were,
in turn, arranged in the channel formed by the host molecules,
which resulted in a “Z” chain structure parallel to the a axis. The
host molecules interacted with the guest molecules through an
intercalation mode. Fig. 3D–F display a space-ﬁlling representa-
tion of bifendate showing the continuous channels along [1 0 0]
viewed down crystallographic a axis for the three solvates. As seen
in the ﬁgure, among these solvates, channels of the forms C and E
were similar but different from that of form D.
3.1.3. Simulated powder X-ray diffraction analysis
The simulated powder X-ray diffraction patterns for each form of
bifendate and solvates C–E after deducting solvents based on the
crystallographic data of forms B–E are given in Fig. 4. As shown,
the simulated PXRD pattern for forms B–E was unique, and the
topologies of PXRD patterns of solvates C to E were similar,
especially for forms C and E. Three strong characteristic peaksfendate molecules in four forms studied.
2–C13–O1 ∠C7–C12–C19–O9 ∠C18–O8–C10–C11
/25.1(4) 24.4(4)/23.5(3) 3.4(3)/7.9(3)
(5) 28.7(5) 5.8(5)
27.2(3) 1.6(4)
(4) 25.9(4) 9.6(5)
Figure 2 Stereochemical structure of form B: (A) a view of the one-dimensional catenoid structure of form B along [0 0 1] direction; (B) a view
of the two-dimensional layer structure of form B along (0 0 1) plane. Molecules are shown as wireframe models and hydrogen atoms are omitted
for clarity.
Jinju Nie et al.238appeared at the 2θ range of 5–101 and 22–281 for forms C–E, and
the values of d were 10.98, 3.67, 3.53 Å (form C); 11.36, 3.77,
3.56 Å (form D); 11.12, 3.63, 3.49 Å (form E) corresponding to
the indices of lattice plane (0 2 0), (1 1 3), (1 2 3); (0 0 2), (1 2 4),
(1 3 2) and (0 2 0), (1 1 3), (1 2 3), for solvates C, D, and E,
respectively. The presence of characteristic peaks coincided well
with the results of SCXRD. Moreover, Fig. 4B–D clearly indicates
that the varying peaks for solvates C–E after deducting solvents,
which can be assigned to the corresponding diffraction peaks of
tetrahydrofuran, dioxane, and pyridine, respectively. Thus, the
varying peaks for solvates C–E, with the d-spacings of 7.94, 6.69,
5.41, 5.07, 4.89, 4.57 , 4.32, 4.14, 4.07, 3.96, 3.90, 3.78, 3.67,
3.53 Å (form C), 7.94 , 5.65, 5.49, 5.15, 5.04, 4.92, 4.60, 4.42 ,
4.20, 4.11, 4.00, 3.95, 3.77, 3.56 Å (form D), and 7.98, 6.68, 6.33,
5.60, 5.35, 4.84, 4.35, 4.12, 3.97, 3.79, 3.70, 3.62, 3.49 Å (form E)
correlated to tetrahydrofuran, dioxane, and pyridine, respectively.3.2. Thermal analysis
To elucidate the thermodynamic behaviors of forms B, C, D, and E
for bifendate, differential scanning calorimetry (DSC) and thermal
gravimetric analysis (TGA) were employed to assess the thermal
events. According to the results of DSC and TGA (Fig. 5), it
further conﬁrmed that, except for form B, forms C–E were all
solvates. For form B, the DSC heating curve showed a single
endothermic peak with a value of 162.82 1C while those of
solvates C–E presented double endothermic peaks. The ﬁrst
endothermic peak values in forms C–E were 77.21 1C,
128.27 1C, and 81.42 1C, respectively, and the second were
182.63 1C, 181.65 1C, and 182.11 1C, respectively. The DSC data
for forms B–E of bifendate are listed in Table 4. The weight loss
of solvents for solvates C, D, and E of bifendate by TGA were
14.57%, 17.13%, and 15.13%, respectively, corresponding to thenumber of the solvent in each asymmetry unit of solvates of 0.99,
0.98, and 0.96, respectively, which was in agreement with the
results of SCXRD.
3.3. IR spectra
With the purpose of further clarifying the distinctions between the
different polymorphs, the FT-IR spectra for forms B–E of
bifendate were studied and assigned on the basis of a careful
comparison between crystalline form B and solvates. As illustrated
in Fig. 6, it was noteworthy that the band appearing at 737 cm1
was the specialized absorption band for form B used to distinguish
from form A but not seen in other solvates20, which was in accord
with the study of DSC. Comparing with form B, it can be found
that the intensity of the bending vibration of the C–H bond from
the methylene group (1464 cm1), together with the stretching
vibration of the C–O bond from methoxyl group (1262 cm1)
decreased sharply in solvates C and E, while that in solvate D
almost disappeared. In addition, the band associated with the δC–C
presenting at 1136 cm1 in form B was shifted considerably
toward lower frequency at 1119 cm1 in form D and was hardly
evident in solvates C and E. Lastly, an apparent distinction in the
ﬁngerprint region with the range of 1000–850 cm1 for all the
four forms was also observed.4. Discussion
Based on the results of SCXRD, form B was a non-solvated
polymorph and forms C–E were solvates. The different space
groups illustrated that the molecular symmetry was different
between the non-solvated form and the three solvates. As seen
in Table 1, the densities of solvates C–E were lower than that of
form B, which indicated the molecules in the structures of forms
Figure 3 Upper row: layered structures of solvates C–E with solvent molecules located in the channels between the layers for (A) solvate C:
tetrahydrofuran, view down c axis; (B) solvate D: dioxane, view down b axis; (C) solvate E: pyridine, view down c axis. Solvent molecules are
represented by spheres corresponding with the van der Waals radii of the respective atoms. Hydrogen atoms are omitted for clarity. Lower row:
space-ﬁlling representation of bifendate showing the continuous channels along [1 0 0] viewed down crystallographic a axis for (D) solvate C:
tetrahydrofuran; (E) solvate D: dioxane and (F) solvate E: pyridine. Bifendate molecules are represented by spheres corresponding with the van der
Waals radii of the respective atoms. Solvents are omitted for clarity.
Study on four polymorphs of bifendate based on X-ray crystallography 239C–E are arranged loosely, and also demonstrated indirectly the
greater thermodynamic stability of form B relative to forms C–E.
Furthermore, the larger calculated volumes of solvent-accessible
voids per the unit-cell volume in solvates C–E implied that big
molecular channels may exist in the stereochemical structure to
hold the solvents molecules for the three solvates.
In the structure of form B, the benzene rings of the biphenyl
group connect with each other in a skew-skew fashion; this led to
two symmetrical fragments linked by the C–C bond of the
biphenyl group and resulted in two different conformational
molecules presented in an asymmetry unit. For the diversity of
the molecular conformation, eight bifendate molecules were
assembled into an asymmetry unit for form B. In comparison
with form B, two different molecular conformations were also
found for solvates C–E; however, because of the adducted
solvents, the C–C bond further rotated and the torsion angle
increased, resulting in two molecular conformations that were
different from that in form B. These adducted solvents had an
important inﬂuence on the conformations of host molecules.
The interactions of the guest with the host evoked our interest.
Theoretically speaking, neither the host molecules nor the guest
molecules contained potentially strong hydrogen bond donors or
acceptors capable of interacting by classical hydrogen bonds in
solvates C–E. In spite of some rigid and planar phenyl rings
present in the host molecules, neither the saturated 5-membered
ring tetrahydrofuran molecules nor the 6-membered ring dioxanemolecules could interact with host molecules by π-π stacking
interactions, while the minimum centroid–centroid separation of
4.340(3) Å was too far for the pyridine rings to generate aromatic
π-π stacking interactions with the phenyl rings of the host. In fact,
as the structure of form B showed, a dihedral angle of approxi-
mately 711 between the two planar fragments existed in the host
molecule because of the rotation of the C–C bond in the biphenyl
skeleton. All the guest solvent molecules for forms C, D, and E
involving tetrahydrofuran, dioxane, and pyridine, respectively,
were planar with suitable volumes, and could be available to
insert into the gap formed by two bifendate molecules. The four
host molecules formed a large cavity in which two guest molecules
could reside through intercalative interactions, with the host
molecules stabilized by weak π-π stacking interactions and non-
classical hydrogen bonds to form a molecular channel, where the
guest molecules arranged by turns forming a “Z” chain structure as
described above. The intercalation mode between guest and host
molecules gave rise to further rotation of the C–C bond and
resulted in the dihedral angle increasing, with the corresponding
value of 125.31 (form C), 125.71 (form D), and 126.71 (form E).
On these grounds, we deduced that to incorporate into the
channel formed by the host molecules, guest molecules should
meet some structural requirements: on one hand, the guest
molecules should be planar so that they could insert into the gap
assembled by the host molecules; on the other hand, the expected
volumes of the guests should be 100–300 Å3 to maintain the
Figure 4 Simulated PXRD pattern for form B and comparison of the simulated PXRD patterns for solvates C–E and those after deducting
solvents of bifendate. (A) form B; (B) solvate C: tetrahydrofuran; 0.5 solvated; unsolvated; (C) solvate D: dioxane; 0.5 solvated; unsolvated;
(D) solvate E: pyridine; 0.5 solvated and unsolvated.
Figure 5 Thermal analysis proﬁles of forms B–E. (A) DSC proﬁles of forms B–E; (B) TGA proﬁles of forms B–E. Proﬁles of forms B–E are
indicated with black, red, blue, and green, respectively. Top to bottom: form B; solvate C: tetrahydrofuran; solvate D: dioxane; and solvate E:
pyridine.
Table 4 DSC data for forms B–E of bifendate.
Form Tdesolv (1C, peak) Tfus (1C, peak)
B – 162.82
C 77.21 182.63
D 128.37 181.65
E 81.42 182.11
Jinju Nie et al.240stability of the molecular structures. This explains why we could
not generate additional solvates with small molecules such as
methanol or ethanol.
The simulated powder X-ray diffraction analysis showed that
the simulated PXRD patterns of forms B to E were unique and the
patterns of all the solvates after deducting the solvents were also
very different. The stated analysis showed that the main diffe-
rences between the four forms were the solvents, the molecular
arrangements and the modes of interaction, which led to the
Figure 6 Infrared spectra for forms B to E of bifendate with
scanning region of 4000–650 cm1. Spectra of forms B to E are
indicated with solid lines in black, red, blue, and green, respectively.
Top to bottom: form B; solvate C: tetrahydrofuran; solvate D: dioxane;
and solvate E: pyridine.
Study on four polymorphs of bifendate based on X-ray crystallography 241differences in the simulated PXRD patterns of forms B–E.
Furthermore, the simulated PXRD patterns of all the solvates after
deducting solvents may allow prediction of other new polymorphs
for bifendate. In the DSC proﬁles, the Tfus value of form B was
162.82 1C and was in agreement with its reported melting point,
which conﬁrmed that form B was a pure non-solvated polymorph.
Among the double endothermic peaks for solvates C–E, the ﬁrst
melting peak can be attributed to that of the solvent while the
second was the endothermic peak of polymorph, with the Tfus
value of 182.63 1C (form C), 181.65 1C (form D), and 182.11 1C
(form E), respectively, consistent with the reported melting point
of form A. This indicated that the three solvates could be
transformed into form A under suitable temperature conditions
because of its greater thermodynamic stability, which was con-
ﬁrmed by desolvation. The differences of the FT-IR spectra for
forms B–E of bifendate indicated that the incorporation of solvents
could affect the molecular arrangement and intermolecular inter-
action mode, and resulted in the changes of the infrared absorption
spectra.5. Conclusions
Our study demonstrates that bifendate has the characteristic of
solvatomorphism. Crystalline form B and three new solvates of
bifendate with structurally similar solvent molecules were obtained
and their crystal structures were characterized. By comparing the
crystal structures of form B with the three solvates C–E, it can be
concluded that, ﬁrstly, weak π-π stacking interactions and non-
classical hydrogen bonds made an important contribution to the
three-dimensional supramolecular structures for the four forms;
secondly, the rotation of the C–C bond of the biphenyl group
together with methyl ester and methoxyl fragments led to distinct
molecular conformations in crystal lattices, which may result in
8 bifendate molecules per asymmetry unit for form B; thirdly, all
the guest solvent molecules interacted with the host molecules
through an intercalation pathway arranged by turns in the channel
formed by the host molecules; lastly, the incorporation of the guest
solvent molecules had an important inﬂuence on the host
molecular conformation. Consequently, we conclude that the guestmolecules should be planar with the expected volumes of
approximately 100–300 Å3 to interact with the bifendate mole-
cules. Moreover, all the three solvates were unstable under high
temperature conditions. SCXRD analysis illustrated that adducted
solvents, the differences in the molecular conformation and the
spatial arrangement caused the formation of polymorphs of
bifendate. In addition, the unique simulated powder X-ray
diffraction patterns were calculated from single crystal experi-
ments of forms B–E and provided a standard for identifying the
purity of polymorphs and solvates. Further investigations on this
and similar systems are in progress in our laboratory.Acknowledgments
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